The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Italian shares jump on Draghi hope; GSK weighs on FTSE 100

Wed, 03rd Feb 2021 09:18

* Milan stocks rise on hopes of Draghi becoming next PM

* Daimler jumps on plan to spin-off truck business

* GSK slides; warns of bigger than expected fall in 2021
earnings
(Updates to close)

By Shreyashi Sanyal and Susan Mathew

Feb 3 (Reuters) - Italian shares posted their best session
in four weeks on Wednesday after former European Central Bank
chief Mario Draghi accepted the task of forming a new
government, while a surge in German carmaker Daimler lifted an
index of broader European shares.

Milan's FTSE MIB index closed up 2.1%, while
Italy's 10-year bond yield tumbled.

Draghi said he was confident of securing sufficient backing
in parliament after President Sergio Mattarella sought his help
after hearing that efforts to salvage the collapsed coalition of
Prime Minister Giuseppe Conte had failed.

"It may not all be plain sailing and some uncertainties and
negotiations remain. But... markets like the news of well-known
central bankers at the helm of government," said Maria Paola
Toschi, global market strategist at J.P. Morgan Asset
Management.

"For the economy, avoiding lengthy further attempts to form
a government should mean that critical near-term issues can be
addressed."

Italy has been hit by the COVID-19 pandemic and economic
crises against the backdrop of political uncertainty battering
the country.

On the pan-European STOXX 600 index Daimler
was the top boost after unveiling plans to spin-off
its trucks business. It rose 8.9% while the broader index gained
0.3%.

Germany's DAX rose 0.7% to hit its highest in two
weeks.

London's blue-chip index slipped 0.1% as
GlaxoSmithKline slid 6.3% after it warned of a bigger
than expected fall in 2021 earnings as the COVID-19 pandemic
continues to disrupt other healthcare treatments.

But upbeat earnings from other companies helped push gains
on the pan-region index to a third straight day, with Novo
Nordisk, Siemens AG, Publicis Groupe SA
all rising after reporting results.

Drugmaker Argenx was the top gainer after it
raised $1 billion in capital increase.

Also keeping sentiment buoyed was hopes of U.S. stimulus
after the Senate took steps to allow Democrats to pass President
Joe Biden's proposed $1.9 trillion COVID-19 aid bill without
Republican support.

European stocks have been steadily rising along with other
major markets after losing more than 3% last week on concerns
around the slow roll-out of COVID-19 vaccines in the euro zone.

A pause in a social media driven rally that drove up prices
of silver as well as certain stocks including GameStop Corp
has helped calm worries about potential losses incurred
by certain hedge funds causing disruption to markets as a whole.
(Reporting by Shreyashi Sanyal in Bengaluru; Editing by Shounak
Dasgupta, Kirsten Donovan)

More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.